雜志介紹

Journal Of Applied Biomedicine雜志介紹

《Journal Of Applied Biomedicine》是一本以English為主的開放獲取國際優(yōu)秀期刊，中文名稱應(yīng)用生物醫(yī)學(xué)雜志，本刊主要出版、報道醫(yī)學(xué)-MEDICINE, RESEARCH & EXPERIMENTAL領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2，最新CiteScore 指數(shù)為2.4。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• RGD peptide doped polypyrrole film as a biomimetic electrode coating for impedimetric sensing of cell proliferation and cytotoxicity

  Author: Yuan Li, Chao Yu

• Effects of Shen-Fu injection on random skin flap survival in rats

  Author: Lin Dingsheng, Wang Long, Jin Zhicheng, Cai Leyi

• Maturation rates of oocytes and levels of FSHR, LHR and GnRHR of COCs response to FSH concentrations in IVM media for sheep

  Author: Wei Suocheng, Gong Zhuandi, Sheng Li, Liang Haoqin, Lai Luju, Deng Yingying

• Hypoglycemic effect of Chrysanthemum morifolium extract on alloxan-induced diabetic mice is associated with peroxisome proliferator-activated receptor α/γ-mediated hepatic glycogen synthesis

  Author: Xiang Shang, Zeng-Yan Zhu, Feng Wang, Jin-Cheng Liu, Jiang-Yun Liu, Mei-Lin Xie

英文介紹

Journal Of Applied Biomedicine雜志英文介紹

Journal of Applied Biomedicine promotes translation of basic biomedical research into clinical investigation, conversion of clinical evidence into practice in all medical fields, and publication of new ideas for conquering human health problems across disciplines.

Providing a unique perspective, this international journal publishes peer-reviewed original papers and reviews offering a sensible transfer of basic research to applied clinical medicine. Journal of Applied Biomedicine covers the latest developments in various fields of biomedicine with special attention to cardiology and cardiovascular diseases, genetics, immunology, environmental health, toxicology, neurology and oncology as well as multidisciplinary studies. The views of experts on current advances in nanotechnology and molecular/cell biology will be also considered for publication as long as they have a direct clinical impact on human health. The journal does not accept basic science research or research without significant clinical implications. Manuscripts with innovative ideas and approaches that bridge different fields and show clear perspectives for clinical applications are considered with top priority.